Request a Program

Leave this field empty

BREAKING THE BARRIERS: Improving Access to Biologic Therapies in IBD

In September 2017, the GiHF partnered with the Chronic Liver Disease Foundation (CLDF) to launch the Gastroenterology and Hepatology Advanced Practice Provider (GHAPP) Community Educator Network including more than 90 NPs and PAs from leading academic centers in gastroenterology and hepatology. The GHAPP Community Educator network is a NP/PA-led working group dedicated to educating allied health care professionals on emerging developments in the management of GI disorders and chronic liver disease. The GHAPP Community Educators will champion the delivery of the GiHF's 'Breaking the Barriers: Improving Access to Biologic Therapies in IBD' educational initiative to NPs and PAs.

The program will feature an in-clinic small group meeting targeting the practice NPs, PAs, nurses, medical assistants and allied health care professionals. It will focus on minimizing access barriers to biologic therapy in IBD with specific emphasis on the prior authorization process for biologics.

Preferred Speaker(pick two)

Preferred Date(pick two)

Preferred Format(pick one)










Request a Program

Thank you!

A representative will contact you shortly.

  • Please select a series
  • IBD

CME Information

Target Audience

This activity is designed for gastroenterologists, nurse practitioners (NPs), physician assistants (PAs) and nurses.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Discuss the real world safety and efficacy of IBD therapies

Discuss the comparative safety and efficacy of anti-TNF and anti-integrin therapies

Understand the underlying biologic pathways relevant to biologic and small molecule therapies

Understand the relevant clinical and mechanistic considerations relating to positioning of IBD therapies

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and IBD ReMEdY. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement:

All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, staff and reviewers of IBD ReMEdY and Purdue University College of Pharmacy have no relationships to disclose.

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Provided by

Accredited by

Americans with Disabilities Act:

The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact us prior to the event at 877-782-4532.

  • Speakers
  • Date
  • Location

Please check back later!

© Copyright 2013-2019 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.